D. Hamstra

发表

Evaluation of the functional diffusion map as an early biomarker of time-to-progression and overall survival in high-grade glioma.

C. Meyer, T. Chenevert, B. Ross, 2005, Proceedings of the National Academy of Sciences of the United States of America.

Real-time evaluation of p53 oscillatory behavior in vivo using bioluminescent imaging.

Alnawaz Rehemtulla, Daniel A Hamstra, Brian D Ross, 2006, Cancer research.

Randomized phase II trial of urethral sparing intensity modulated radiation therapy in low-risk prostate cancer: implications for focal therapy

H. Sandler, D. Hamstra, C. Pan, 2012, Radiation Oncology.

Diffusion magnetic resonance imaging: a biomarker for treatment response in oncology.

B. Ross, A. Rehemtulla, D. Hamstra, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Noninvasive real-time imaging of apoptosis

Thomas L. Chenevert, Alnawaz Rehemtulla, Brian D. Ross, 2002, Proceedings of the National Academy of Sciences of the United States of America.

Functional diffusion map as an early imaging biomarker for high-grade glioma: correlation with conventional radiologic response and overall survival.

Timothy D Johnson, Alnawaz Rehemtulla, Thomas L Chenevert, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Parametric response map as an imaging biomarker to distinguish progression from pseudoprogression in high-grade glioma.

Timothy D Johnson, Alnawaz Rehemtulla, Thomas L Chenevert, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The extent and severity of vascular leakage as evidence of tumor aggressiveness in high-grade gliomas.

T. Chenevert, V. Nagesh, B. Ross, 2006, Cancer research.

Supporting Information for Predicting Treatment Efficacy via Quantitative MRI : A Bayesian Joint Model by

C. Meyer, T. Chenevert, T. Johnson, 2011 .

Rectal Spacer Usage with Proton Radiation Therapy for Prostate Cancer.

D. Hamstra, A. Thompson, 2020, International journal of radiation oncology, biology, physics.

Hypofractionation in Prostate Cancer Using Proton Beam.

D. Hamstra, T. Quinn, 2019, International journal of radiation oncology, biology, physics.

Changes in prostate orientation due to removal of a Foley catheter

W. Jackson, J. Hearn, M. Schipper, 2018, Medical physics.

A measurement technique to determine the calibration accuracy of an electromagnetic tracking system to radiation isocenter.

K. Lam, J. Prisciandaro, Choonik Lee, 2013, Medical physics.

Expression of endogenously activated secreted or cell surface carboxypeptidase A sensitizes tumor cells to methotrexate-alpha-peptide prodrugs.

A. Rehemtulla, D. Hamstra, J. Maybaum, 2000, Cancer research.

Fusion of the HSV-1 tegument protein vp22 to cytosine deaminase confers enhanced bystander effect and increased therapeutic benefit

A. Rehemtulla, B. Moffat, D. Hamstra, 2006, Gene Therapy.

Toward an enzyme/prodrug strategy for cancer gene therapy: endogenous activation of carboxypeptidase A mutants by the PACE/Furin family of propeptidases.

A. Rehemtulla, D. Hamstra, Daniel A. Hamstra, 1999, Human gene therapy.

Enzyme/prodrug therapy for head and neck cancer using a catalytically superior cytosine deaminase.

A. Rehemtulla, D. Hamstra, B. Ross, 1999, Human gene therapy.

Dose to the inferior rectum is strongly associated with patient reported bowel quality of life after radiation therapy for prostate cancer.

H. Sandler, F. Feng, M. Sanda, 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

High-risk Prostate Cancer Treated With Dose-escalated RT: An Analysis of Hormonal Therapy Use and Duration, and Prognostic Implications of PSA Nadir ⩽0.2 to Select Men for Short-term Hormonal Therapy

F. Feng, D. Hamstra, S. Liauw, 2017, American journal of clinical oncology.

The percent of positive biopsy cores improves prediction of prostate cancer-specific death in patients treated with dose-escalated radiotherapy.

H. Sandler, F. Feng, D. Hamstra, 2011, International journal of radiation oncology, biology, physics.

Percentage of cancer volume in biopsy cores is prognostic for prostate cancer death and overall survival in patients treated with dose-escalated external beam radiotherapy.

F. Feng, D. Hamstra, M. Stenmark, 2011, International journal of radiation oncology, biology, physics.

Impact of tertiary Gleason pattern 5 on prostate cancer aggressiveness: Lessons from a contemporary single institution radical prostatectomy series

John T. Wei, David C. Miller, A. Chinnaiyan, 2014, Asian journal of urology.

Hydrogel Spacer Prospective Multicenter Randomized Controlled Pivotal Trial: Dosimetric and Clinical Effects of Perirectal Spacer Application in Men Undergoing Prostate Image Guided Intensity Modulated Radiation Therapy.

J. Sylvester, D. Beyer, T. DeWeese, 2015, International journal of radiation oncology, biology, physics.

Gleason pattern 5 is the strongest pathologic predictor of recurrence, metastasis, and prostate cancer–specific death in patients receiving salvage radiation therapy following radical prostatectomy

R. Mehra, W. Jackson, F. Feng, 2013, Cancer.

Gleason pattern 5 is associated with an increased risk for metastasis following androgen deprivation therapy and radiation: An analysis of RTOG 9202 and 9902.

Christopher U. Jones, K. Pienta, H. Sandler, 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

MDM2 Inhibition Sensitizes Prostate Cancer Cells to Androgen Ablation and Radiotherapy in a p53-Dependent Manner12

Shaomeng Wang, W. Jackson, F. Feng, 2016, Neoplasia.

VA-Radiation Oncology Quality Surveillance Program.

L. Potters, I. Chetty, J. DeMarco, 2020, International journal of radiation oncology, biology, physics.

Combination therapy improves prostate cancer survival for patients with potentially lethal prostate cancer: The impact of Gleason pattern 5.

H. Sandler, P. McLaughlin, F. Feng, 2011, Brachytherapy.

Do not count out external-beam radiation therapy for high-risk prostate cancer.

H. Sandler, J. Michalski, D. Hamstra, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Complications of prostate cancer treatment.

Ronald C. Chen, A. Zietman, H. Sandler, 2014, The Lancet. Oncology.

Limitations of the Cancer of the Prostate Risk Assessment (CAPRA) Prognostic Tool for Prediction of Metastases and Prostate Cancer-specific Mortality in Patients Treated With External Beam Radiation Therapy

F. Feng, M. Schipper, D. Hamstra, 2016, American journal of clinical oncology.

Larger maximum tumor diameter at radical prostatectomy is associated with increased biochemical failure, metastasis, and death from prostate cancer after salvage radiation for prostate cancer.

R. Mehra, H. Sandler, W. Jackson, 2013, International journal of radiation oncology, biology, physics.

Dosimetric implications of residual seminal vesicle motion in fiducial-guided intensity-modulated radiotherapy for prostate cancer.

R. T. Ten Haken, K. Vineberg, D. Hamstra, 2012, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

Patient-Reported Sexual Aid Utilization and Efficacy After Radiation Therapy for Localized Prostate Cancer.

Clayton P Smith, David C. Miller, T. Skolarus, 2018, International journal of radiation oncology, biology, physics.

Erectile function after stereotactic body radiotherapy for localized prostate cancer

R. Mehra, R. Dess, W. Jackson, 2018, BJU international.

Age and comorbid illness are associated with late rectal toxicity following dose-escalated radiation therapy for prostate cancer.

W. Jackson, F. Feng, D. Hamstra, 2013, International journal of radiation oncology, biology, physics.

Defining a standard set of patient-centered outcomes for men with localized prostate cancer.

Steven J Frank, Thomas Wiegel, Ronald C. Chen, 2014, European urology.

Patient reported outcomes for quality of life (QOL) by Expanded Prostate Cancer Index (EPIC) on average 15 years post treatment

H. Sandler, P. McLaughlin, W. Jackson, 2022, Clinical and translational radiation oncology.

Inhibition of mTOR Radiosensitizes Soft Tissue Sarcoma and Tumor Vasculature

James D. Murphy, D. Hamstra, S. Markwart, 2007, Clinical Cancer Research.

Spinal Growth Patterns After Craniospinal Irradiation in Children With Medulloblastoma.

D. Hamstra, Michelle M. Kim, K. Oh, 2019, Practical radiation oncology.

Patient-Reported Quality of Life During Prostate Cancer Radiation Therapy: Insights Into the Patient Experience.

D. Hamstra, J. S. Parzen, 2021, International journal of radiation oncology, biology, physics.

2532 : Does the Pattern of Failure Impact the Use of Single-Agent 131I-Tositumomab for Follicular Lymphoma?

M. Kaminski, R. Wahl, I. Francis, 2006 .

Salvage Radiation Therapy Improves Metastasis-free Survival for Clinically Aggressive and Indolent Prostate Cancer Recurrences After Radical Prostatectomy

W. Jackson, F. Feng, D. Hamstra, 2015, American journal of clinical oncology.

Extracellular expression of cytosine deaminase results in increased 5-FU production for enhanced enzyme/prodrug therapy.

A. Rehemtulla, T. Lawrence, D. Hamstra, 2004, Anticancer research.

Predictors of follow-up non-compliance after definitive radiotherapy for locally advanced cervical cancer at a community cancer center

D. Hamstra, M. Ludwig, L. Sapienza, 2022, Gynecologic Oncology Reports.

Evaluation of d-Methionine as a Novel Oral Radiation Protector for Prevention of Mucositis

B. Ross, A. Rehemtulla, D. Hamstra, 2008, Clinical Cancer Research.

A multi-institutional phase 2 trial of prostate stereotactic body radiation therapy (SBRT) using continuous real-time evaluation of prostate motion with patient-reported quality of life.

John T. Wei, H. Sandler, R. Dess, 2018, Practical radiation oncology.

Brainstem Low-Grade Gliomas in Children—Excellent Outcomes With Multimodality Therapy

P. Robertson, K. Muraszko, D. Hamstra, 2017, Journal of Child Neurology.

Treatment Modality for Localized Prostate Cancer Yields Superior Quality of Life : Radiotherapy or Prostatectomy ?

D. Hamstra, Byunghyuk Yu, 2017 .

Long‐term follow‐up after radiotherapy for prostate cancer with and without rectal hydrogel spacer: a pooled prospective evaluation of bowel‐associated quality of life

W. Bosch, D. Hamstra, M. Pinkawa, 2020, BJU international.

In Reply to King et al.

D. Hamstra, Neil Mariados, 2015, International journal of radiation oncology, biology, physics.

Perineural invasion predicts increased recurrence, metastasis, and death from prostate cancer following treatment with dose-escalated radiation therapy.

H. Sandler, F. Feng, D. Hamstra, 2011, International journal of radiation oncology, biology, physics.

Concurrent whole brain radiotherapy and bortezomib for brain metastasis

B. Redman, Yue Cao, J. Hayman, 2013, Radiation oncology.

Hormonal status effects on the electrophysiological correlates of performance monitoring in women

D. Hamstra, M. D. Rover, E. D. Bruijn, 2022, Psychoneuroendocrinology.

Primary radiotherapy for childhood ependymoma?

D. Hamstra, 2007, The Lancet. Oncology.

Effect of Standard vs Dose-Escalated Radiation Therapy for Patients With Intermediate-Risk Prostate Cancer: The NRG Oncology RTOG 0126 Randomized Clinical Trial

H. Sandler, M. Lock, J. Purdy, 2018, JAMA oncology.

PHOTOCHEMISTRY OF 1-ALKOXY- AND 1-(BENZYLOXY)-9,10-ANTHRAQUINONES IN METHANOL : A DELTA -HYDROGEN ATOM ABSTRACTION PROCESS THAT EXHIBITS A CAPTODATIVE EFFECT

D. Hamstra, R. Blankespoor, P. Vink, 1991 .

The use of 19F spectroscopy and diffusion-weighted MRI to evaluate differences in gene-dependent enzyme prodrug therapies.

Bradford A Moffat, Alnawaz Rehemtulla, Thomas L Chenevert, 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

The Cancer of the Prostate Risk Assessment (CAPRA) in patients treated with external beam radiation therapy: evaluation and optimization in patients at higher risk of relapse.

H. Sandler, F. Feng, M. Schipper, 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Co-Inhibition of Androgen Receptor and PARP as a Novel Treatment Paradigm in Prostate Cancer—Where Are We Now?

D. Hamstra, C. Ryan, Arpit Rao, 2022, Cancers.

Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy.

T L Chenevert, A. Chinnaiyan, T. Chenevert, 2000, Proceedings of the National Academy of Sciences of the United States of America.

Lack of cell surface Fas/APO-1 expression in pulmonary adenocarcinomas.

D. Beer, M. Orringer, A. Rehemtulla, 1998, The Journal of clinical investigation.

Fas/APO-1 (CD95) is not translocated to the cell membrane in esophageal adenocarcinoma.

D. Beer, M. Iannettoni, M. Orringer, 1997, Cancer research.

Salvage external beam radiotherapy for prostate cancer after radical prostatectomy: current status and controversy.

A. Raldow, D. Hamstra, James B. Yu, 2010, Oncology.

Outcomes of multidisciplinary management in pediatric low-grade gliomas.

H. Sandler, P. Robertson, K. Muraszko, 2008, International journal of radiation oncology, biology, physics.

Gemcitabine-mediated radiosensitization of human soft tissue sarcoma.

James D. Murphy, D. Hamstra, D. Lucas, 2008, Translational oncology.

Contemporary Update of a Multi-Institutional Predictive Nomogram for Salvage Radiotherapy After Radical Prostatectomy.

Shree Agrawal, Daniel A Hamstra, Jeff M Michalski, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Salvage Radiation Therapy Dose Response for Biochemical Failure of Prostate Cancer After Prostatectomy-A Multi-Institutional Observational Study.

M. Kattan, A. Zietman, M. Anscher, 2016, International journal of radiation oncology, biology, physics.

A Phase 3 Trial of 2 Years of Androgen Suppression and Radiation Therapy With or Without Adjuvant Chemotherapy for High-Risk Prostate Cancer: Final Results of Radiation Therapy Oncology Group Phase 3 Randomized Trial NRG Oncology RTOG 9902.

Christopher U. Jones, K. Pienta, D. Grignon, 2015, International journal of radiation oncology, biology, physics.

Continued benefit to androgen deprivation therapy for prostate cancer patients treated with dose-escalated radiation therapy across multiple definitions of high-risk disease.

H. Sandler, F. Feng, D. Hamstra, 2011, International journal of radiation oncology, biology, physics.

Counseling patients about sexual health when considering post-prostatectomy radiation treatment

J. Montie, D. Hamstra, D. Wittmann, 2009, International Journal of Impotence Research.

A comprehensive assessment of the prognostic utility of the Stephenson nomogram for salvage radiation therapy postprostatectomy.

W. Jackson, F. Feng, D. Hamstra, 2014, Practical radiation oncology.

Impact of biochemical failure classification on clinical outcome: A secondary analysis of Radiation Therapy Oncology Group 9202 and 9413

H. Sandler, K. Bae, W. Shipley, 2015, Cancer.

Older age predicts decreased metastasis and prostate cancer-specific death for men treated with radiation therapy: meta-analysis of radiation therapy oncology group trials.

D. Grignon, H. Sandler, K. Bae, 2011, International journal of radiation oncology, biology, physics.

Carboxy-terminal conversion of profibrillin to fibrillin at a basic site by PACE/furin-like activity required for incorporation in the matrix.

M. Raghunath, D. Milewicz, A. Rehemtulla, 1999, Journal of cell science.

Imaging of Proteolytic Activity Using a Conditional Cell Surface Receptor

B. Ross, A. Rehemtulla, D. Hamstra, 2006, Molecular imaging.

Double‐blind placebo‐controlled multicenter phase II trial to evaluate D‐methionine in preventing/reducing oral mucositis induced by radiation and chemotherapy for head and neck cancer

B. Ross, A. Rehemtulla, D. Hamstra, 2018, Head & neck.

Pharmacokinetic Analysis and Phase 1 Study of MRX-1024 in Patients Treated with Radiation Therapy with or without Cisplatinum for Head and Neck Cancer

G. V. Ramana, B. Ross, A. Rehemtulla, 2010, Clinical Cancer Research.

High-Risk Prostate Cancer: Local Therapy Matters

D. Hamstra, A. Liss, 2015 .

Trimodality therapy for atypical teratoid/rhabdoid tumor is associated with improved overall survival: A surveillance, epidemiology, and end results analysis

Zaid A. Siddiqui, D. Hamstra, Peter Y. Chen, 2019, Pediatric blood & cancer.

Treatment Outcomes in Very High-risk Prostate Cancer Treated by Dose-escalated and Combined-Modality Radiation Therapy

G. Merrick, P. McLaughlin, D. Hamstra, 2016, American journal of clinical oncology.

Ageism in the undertreatment of high-risk prostate cancer: how long will clinical practice patterns resist the weight of evidence?

D. Hamstra, D. Shumway, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Osteochondromas After Radiation for Pediatric Malignancies: A Role for Expanded Counseling for Skeletal Side Effects

Y. Li, D. Hanauer, D. Hamstra, 2014, Journal of pediatric orthopedics.

Oral D-methionine protects against cisplatin-induced hearing loss in humans: phase 2 randomized clinical trial in India

D. Hamstra, P. Sunkara, K. Campbell, 2021, International journal of audiology.

Concurrent gemcitabine and radiotherapy for the treatment of muscle-invasive bladder cancer: A pooled individual data analysis of eight phase I-II trials.

D. Hamstra, M. D. De Santis, A. Choudhury, 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Expression of ribonucleoside reductase subunit M1, but not excision repair cross-complementation group 1, is predictive in muscle-invasive bladder cancer treated with chemotherapy and radiation.

Dafydd G. Thomas, D. Hamstra, A. Wu, 2014, Molecular and clinical oncology.

Preparing Patients with Early Stage Prostate Cancer to Participate in Clinical Appointments Using a Shared Decision Making Training Video

Karen A. Scherr, John T. Wei, Valerie C. Kahn, 2021, Medical decision making : an international journal of the Society for Medical Decision Making.

Prospective Analysis of Parametric Response Map–Derived MRI Biomarkers: Identification of Early and Distinct Glioma Response Patterns Not Predicted by Standard Radiographic Assessment

Timothy D Johnson, Alnawaz Rehemtulla, Thomas L Chenevert, 2011, Clinical Cancer Research.

Prospective analysis of parametric MRI biomarkers : Identification of early and distinct glioma response patterns not predicted by standard radiographic assessment

C. Meyer, T. Chenevert, B. Ross, 2011 .

A Multi-Institutional Experience in Pediatric High-Grade Glioma

M. Guiou, S. Walston, A. Chakravarti, 2015, Front. Oncol..

Symptom burden and information needs in prostate cancer survivors: a case for tailored long‐term survivorship care

D. Haggstrom, T. Skolarus, S. Hawley, 2016, BJU international.

Acute and late urinary toxicity following radiation in men with an intact prostate gland or after a radical prostatectomy: A secondary analysis of RTOG 94-08 and 96-01.

Christopher U. Jones, R. Mak, H. Sandler, 2016, Urologic oncology.

Multinational Prospective Study of Patient-Reported Outcomes After Prostate Radiation Therapy: Detailed Assessment of Rectal Bleeding.

D. Kuban, I. Kaplan, O. Garin, 2016, International journal of radiation oncology, biology, physics.

Oral contraceptives positively affect mood in healthy PMS-free women: A longitudinal study.

D. Hamstra, E. D. de Kloet, Mischa de Rover, 2017, Journal of psychosomatic research.

Mineralocorticoid receptor haplotype, estradiol, progesterone and emotional information processing

W. Does, D. Hamstra, Ina Quataert, 2017, Psychoneuroendocrinology.

Mineralocorticoid receptor haplotype moderates the effects of oral contraceptives and menstrual cycle on emotional information processing

B. Verkuil, W. Does, D. Hamstra, 2016, Journal of psychopharmacology.

The Impact of Numeracy on Verbatim Knowledge of the Longitudinal Risk for Prostate Cancer Recurrence following Radiation Therapy

B. Zikmund‐Fisher, A. Fagerlin, D. Hamstra, 2015, Medical decision making : an international journal of the Society for Medical Decision Making.

Predicting treatment efficacy via quantitative magnetic resonance imaging: a Bayesian joint model

Timothy D Johnson, Alnawaz Rehemtulla, Thomas L Chenevert, 2012, Journal of the Royal Statistical Society. Series C, Applied statistics.

Multi-institutional prospective evaluation of bowel quality of life after prostate external beam radiation therapy identifies patient and treatment factors associated with patient-reported outcomes: the PROSTQA experience.

John T. Wei, D. Kuban, I. Kaplan, 2013, International journal of radiation oncology, biology, physics.

A feasibility study of parametric response map analysis of diffusion-weighted magnetic resonance imaging scans of head and neck cancer patients for providing early detection of therapeutic efficacy.

Bradford A Moffat, Timothy D Johnson, Avraham Eisbruch, 2009, Translational oncology.

Noninvasive Molecular Imaging Sheds Light on the Synergy between 5-Fluorouracil and TRAIL/Apo2L for Cancer Therapy

B. Ross, A. Rehemtulla, D. Hamstra, 2007, Clinical Cancer Research.

Continued Benefit to Rectal Separation for Prostate Radiation Therapy: Final Results of a Phase III Trial.

Hiram Gay, Anupama Chundury, Rodney Ellis, 2017, International journal of radiation oncology, biology, physics.

Self-reported Conflicts of Interest and Trial Sponsorship of Clinical Trials in Prostate Cancer Involving Radiotherapy

F. Feng, D. Spratt, D. Hamstra, 2015, American journal of clinical oncology.

Application of a Prognostic Stratification System for High-risk Prostate Cancer to Patients Treated With Radiotherapy: Implications for Treatment Optimization

G. Merrick, P. McLaughlin, R. Dess, 2019, American journal of clinical oncology.

A randomized trial of 79.2Gy versus 70.2Gy radiation therapy (RT) for localized prostate cancer.

H. Sandler, M. Lock, J. Purdy, 2015 .

The parametric response map is an imaging biomarker for early cancer treatment outcome

Timothy D Johnson, Alnawaz Rehemtulla, Thomas L Chenevert, 2009, Nature Medicine.

Therapeutic Efficacy of DTI-015 using Diffusion Magnetic Resonance Imaging as an Early Surrogate Marker

Bradford A Moffat, Timothy D Johnson, Alnawaz Rehemtulla, 2004, Clinical Cancer Research.

Time to Nadir PSA: Of Popes and PSA—The Immortality Bias

W. Jackson, F. Feng, D. Hamstra, 2015, American journal of clinical oncology.

Combining prostate-specific antigen nadir and time to nadir allows for early identification of patients at highest risk for development of metastasis and death following salvage radiation therapy.

W. Jackson, F. Feng, D. Hamstra, 2014, Practical radiation oncology.

Combining Prostate-Specific Antigen Nadir and Time to Nadir Allows for Early Identification of Patients at Highest Risk for Development of Metastasis and Death Following Salvage Radiation Therapy

H. Sandler, W. Jackson, F. Feng, 2013 .

A prostate-specific antigen doubling time of <6 months is prognostic for metastasis and prostate cancer-specific death for patients receiving salvage radiation therapy post radical prostatectomy

H. Sandler, W. Jackson, T. Morgan, 2013, Radiation oncology.

Gleason pattern 5 is the greatest risk factor for clinical failure and death from prostate cancer after dose-escalated radiation therapy and hormonal ablation.

H. Sandler, F. Feng, D. Hamstra, 2011, International journal of radiation oncology, biology, physics.

Relief of Urinary Symptom Burden after Primary Prostate Cancer Treatment

John T. Wei, I. Kaplan, A. Kibel, 2017, The Journal of urology.

Prediction of erectile function following treatment for prostate cancer.

John T. Wei, M. Cooperberg, P. Carroll, 2011, JAMA.

Less advanced disease at initiation of salvage androgen deprivation therapy is associated with decreased mortality following biochemical failure post-salvage radiation therapy

W. Jackson, F. Feng, D. Hamstra, 2014, Radiation oncology.

A phase 2 trial of salvage radiation and concurrent weekly docetaxel after a rising prostate-specific antigen level after radical prostatectomy

K. Pienta, S. Jolly, K. Cooney, 2015, Advances in radiation oncology.

Long-term Androgen Deprivation Therapy Improves Metastasis Free and Cause-specific Survival Even in the Setting of Dose Escalated Radiation for Localized Prostate Cancer

H. Sandler, F. Feng, D. Hamstra, 2010 .

Time Interval to Biochemical Failure as a Surrogate End Point in Locally Advanced Prostate Cancer: Analysis of Randomized Trial NRG/RTOG 9202.

D. Grignon, H. Sandler, H. Lepor, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The Central Role of Radiation in Prolonging Survival for High-Risk Prostate Cancer

D. Hamstra, D. Shumway, 2015 .

High-throughput transcriptomic analysis nominates proteasomal genes as age-specific biomarkers and therapeutic targets in prostate cancer

E. Klein, W. Jackson, E. Davicioni, 2015, Prostate Cancer and Prostatic Disease.

Clinicopathologic characteristics of anterior prostate cancer (APC), including correlation with previous biopsy pathology

John T. Wei, A. Chinnaiyan, S. Tomlins, 2015, Medical Oncology.

Anatomical patterns of recurrence following biochemical relapse after post‐prostatectomy salvage radiation therapy: a multi‐institutional study

David C. Miller, R. Hannan, M. Folkert, 2017, BJU international.

The interval to biochemical failure is prognostic for metastasis, prostate cancer-specific mortality, and overall mortality after salvage radiation therapy for prostate cancer.

W. Jackson, F. Feng, D. Hamstra, 2013, International journal of radiation oncology, biology, physics.

Independent validation of the prognostic capacity of the ISUP prostate cancer grade grouping system for radiation treated patients with long-term follow-up

S. Tomlins, R. Mehra, H. Sandler, 2016, Prostate Cancer and Prostatic Diseases.

Patient-reported quality of life after stereotactic body radiotherapy (SBRT), intensity modulated radiotherapy (IMRT), and brachytherapy.

John T. Wei, T. Skolarus, D. Kuban, 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Integrating webinar and blogging technologies into chemistry seminar

D. Hamstra, J. Kemsley, Dave W. Randall, 2011 .

Neoadjuvant androgen deprivation therapy leads to immediate impairment of vitality/hormonal and sexual quality of life: results of a multicenter prospective study.

John T. Wei, D. Kuban, R. Dunn, 2013, Urology.

Contribution : Knowledge-based treatment planning and its potential role in the transition between treatment planning systems

Martha Matuszak, Matthew Schipper, W. Jackson, 2017 .

Diffusion magnetic resonance imaging: an imaging treatment response biomarker to chemoradiotherapy in a mouse model of squamous cell cancer of the head and neck.

T. Chenevert, B. Ross, A. Rehemtulla, 2008, Translational oncology.

Adjuvant radiotherapy after radical prostatectomy: evidence and analysis.

A. Raldow, D. Hamstra, James B. Yu, 2011, Cancer treatment reviews.

Prostate Intrafraction Translation Margins for Real-Time Monitoring and Correction Strategies

T. Solberg, J. Balter, H. Sandler, 2011, Prostate cancer.

Mineralocorticoid receptor haplotype, oral contraceptives and emotional information processing

D. Hamstra, E. D. Kloet, A. M. Hemert, 2015, Neuroscience.

Revoking the Privilege: Targeting HER2 in the Central Nervous System

D. Hamstra, J. Contessa, 2008, Molecular Pharmacology.

Interval to biochemical failure predicts clinical outcomes in patients with high-risk prostate cancer treated by combined-modality radiation therapy.

Daniel A Hamstra, G. Merrick, P. McLaughlin, 2013, International journal of radiation oncology, biology, physics.

The addition of low‐dose‐rate brachytherapy and androgen‐deprivation therapy decreases biochemical failure and prostate cancer death compared with dose‐escalated external‐beam radiation therapy for high‐risk prostate cancer

G. Merrick, H. Sandler, P. McLaughlin, 2013, Cancer.

The dosimetric impact of prostate rotations during electromagnetically guided external-beam radiation therapy.

Scott Hadley, Daniel A Hamstra, Karen Vineberg, 2013, International journal of radiation oncology, biology, physics.

Oral contraceptives may alter the detection of emotions in facial expressions

W. Does, D. Hamstra, M. D. Rover, 2014, European Neuropsychopharmacology.

Absorbable Hydrogel Spacer Use in Prostate Radiotherapy: A Comprehensive Review of Phase 3 Clinical Trial Published Data.

Misop Han, P. Nieh, D. Hamstra, 2017, Urology.

External Beam Radiation Therapy or Brachytherapy With or Without Short-course Neoadjuvant Androgen Deprivation Therapy: Results of a Multicenter, Prospective Study of Quality of Life.

John T. Wei, D. Kuban, R. Dunn, 2017, International journal of radiation oncology, biology, physics.

Interval to biochemical failure as a biomarker for cause‐specific and overall survival after dose‐escalated external beam radiation therapy for prostate cancer

H. Sandler, F. Feng, D. Hamstra, 2012, Cancer.

Spermatogenesis After Testicular Radiation Exposure in Children: Initial Results from the Pediatric Normal Tissue Effects in the Clinic (PENTEC) Initiative

L. Cohen, I. Naqa, L. Constine, 2019, International Journal of Radiation Oncology, Biology, Physics.

Initial Results of a Phase 3 Randomized Study of High Dose 3DCRT/IMRT versus Standard Dose 3D-CRT/IMRT in Patients Treated for Localized Prostate Cancer (RTOG 0126)

H. Sandler, M. Lock, J. Purdy, 2014 .

Diffusion MRI detects early events in the response of a glioma model to the yeast cytosine deaminase gene therapy strategy

A. Rehemtulla, D. Hamstra, LD Stegman, 2000, Gene Therapy.

Reply to G. Gandaglia et al and K. Lu.

D. Hamstra, D. Shumway, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Combined radiation and enzyme/prodrug treatment for head and neck cancer in an orthotopic animal model.

A. Rehemtulla, D. Hamstra, A. Pu, 1999, Radiation research.

Development of a Novel Erizyme/Prodrug Strategy for Gene Therapy of Breast Cancer.

A. Rehemtulla, D. Hamstra, 1998 .

Predictors of Multidomain Decline in Health-Related Quality of Life After Stereotactic Body Radiation Therapy (SBRT) for Prostate Cancer

R. Dess, W. Jackson, F. Feng, 2016 .

Sexual quality of life following prostate intensity modulated radiation therapy (IMRT) with a rectal/prostate spacer: Secondary analysis of a phase 3 trial.

J. Sylvester, D. Beyer, T. DeWeese, 2018, Practical radiation oncology.

Duration of Androgen Deprivation Therapy Influences Outcomes for Patients Receiving Radiation Therapy Following Radical Prostatectomy.

H. Sandler, W. Jackson, F. Feng, 2016, European urology.

Continued Benefit to Rectal Separation for Prostate RT: Final Results of a Phase III Trial

J. Sylvester, D. Beyer, T. DeWeese, 2016 .

Patient‐reported outcomes after 3‐dimensional conformal, intensity‐modulated, or proton beam radiotherapy for localized prostate cancer

A. Zietman, H. Sandler, B. Yeap, 2013, Cancer.

Predictors of multidomain decline in health‐related quality of life after stereotactic body radiation therapy (SBRT) for prostate cancer

R. Dess, W. Jackson, F. Feng, 2017, Cancer.

Anatomic Variability of the Neurovascular Elements Defined by MRI

P. McLaughlin, V. Narayana, D. Hamstra, 2014 .

Comparative effectiveness study of patient‐reported outcomes after proton therapy or intensity‐modulated radiotherapy for prostate cancer

H. Sandler, M. Regan, M. Sanda, 2014, Cancer.

General Commentary to the “Management of Biochemical Recurrence after Primary Localized Therapy for Prostate Cancer” by Darwish O. M. and Raj G. V.

F. Feng, D. Hamstra, M. Shilkrut, 2012, Front. Oncol..

Inhibition of Vascular Endothelial Growth Factor (VEGF)-A Causes a Paradoxical Increase in Tumor Blood Flow and Up-Regulation of VEGF-D

T. Chenevert, B. Ross, J. Stojanovska, 2006, Clinical Cancer Research.

Oncology scan--intermittent androgen deprivation and the randomized evidence.

D. Hamstra, 2013, International journal of radiation oncology, biology, physics.

ETHICAL ALLOCATION OF PROTON THERAPY AND THE INSURANCE REVIEW PROCESS.

C. Stevens, D. Hamstra, P. Chinnaiyan, 2021, Practical radiation oncology.

Counseling patients about sexual health when considering post-prostatectomy radiation treatment

J. Montie, D. Hamstra, D. Wood, 2009, International Journal of Impotence Research.

Radiation therapy reduces local failure and improves overall survival in sPNET

D. Hamstra, A. Spalding, 2008, Pediatric blood & cancer.

From the guest editor: Proton therapy: current evidence, challenges, and future plans.

D. Hamstra, 2014, Cancer journal.

Proton Therapy: Current Evidence, Challenges, and Future Plans

D. Hamstra, 2014 .

Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy.

A. Chinnaiyan, T. Chenevert, A. Rehemtulla, 2000, Proceedings of the National Academy of Sciences of the United States of America.

Randomized phase II trial of urethral sparing intensity modulated radiation therapy in low-risk prostate cancer: implications for focal therapy

H. Sandler, D. Hamstra, C. Pan, 2012, Radiation oncology.

RE: Mortality after radical prostatectomy or external beam radiotherapy for localized prostate cancer.

Ronald C. Chen, D. Hamstra, 2014, Journal of the National Cancer Institute.

Retrospective evaluation reveals that long-term androgen deprivation therapy improves cause-specific and overall survival in the setting of dose-escalated radiation for high-risk prostate cancer.

H. Sandler, F. Feng, D. Hamstra, 2013, International journal of radiation oncology, biology, physics.

Treatment Outcomes in Very High-risk Prostate Cancer Treated by Dose-escalated and Combined-Modality Radiation Therapy

G. Merrick, D. Hamstra, J. Vainshtein, 2016, American journal of clinical oncology.

Prediction of erectile function following treatment for prostate cancer.

John T. Wei, M. Cooperberg, P. Carroll, 2011, JAMA.

Oral contraceptives may alter the detection of emotions in facial expressions

W. Does, D. Hamstra, M. D. Rover, 2014, European Neuropsychopharmacology.

Oral contraceptives positively affect mood in healthy PMS-free women: A longitudinal study.

W. Does, D. Hamstra, M. D. Rover, 2017, Journal of psychosomatic research.

Comparative effectiveness study of patient‐reported outcomes after proton therapy or intensity‐modulated radiotherapy for prostate cancer

H. Sandler, M. Regan, M. Sanda, 2014, Cancer.

Prostaglandin-Induced Activation of Nociceptive Neurons via Direct Interaction with Transient Receptor Potential A1 (TRPA1)

E. Mazzon, D. Hamstra, J. Contessa, 2008, Molecular Pharmacology.

A pooled long-term follow-up after radiotherapy for prostate cancer with and without a rectal hydrogel spacer: impact of hydrogel on decline in sexual quality of life

D. Hamstra, M. Pinkawa, Z. Seymour, 2023, Frontiers in oncology.

Apparent diffusion coefficient values predict response to brachytherapy in bulky cervical cancer

D. Hamstra, Elizabeth E. Dong, Junqian Xu, 2024, Radiation oncology.

Gleason pattern 5 is associated with an increased risk for metastasis following androgen deprivation therapy and radiation: An analysis of RTOG 9202 and 9902.

Christopher U. Jones, K. Pienta, H. Sandler, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Quality of life is not compromised with intensification of androgen therapy in recurrent prostate cancer.

D. Hamstra, Z. Seymour, 2018, The Lancet. Oncology.